Anti-Amyloid Precursor Protein antibody [EPR5118-34]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(13 Publications)
Knockout Tested Rabbit Recombinant Monoclonal Amyloid-beta precursor protein antibody. Suitable for IHC-P, WB, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 13 publications.
View Alternative Names
A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Amyloid Precursor Protein antibody [EPR5118-34] (AB126732)
Overlay histogram showing A431 cells stained with ab126732 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab126732, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Amyloid Precursor Protein antibody [EPR5118-34] (AB126732)
ab126732, at a dilution of 1/100, staining Amyloid Precursor Protein in paraffin-embedded Human fetal brain tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-Amyloid Precursor Protein antibody [EPR5118-34] (AB126732)
This blot was produced using 4-20% SDS-PAGE containing 15 μg of HEK-293 whole cell lysate per lane at 150V for 1hr before being transferred onto a 0.45 μm PVDF membrane at 75V for 1hr. The membrane was then blocked for 1hr using 5% NFDM/TBST, then incubated with ab126732 (1/1000) at room temperature for 1hr. After being washed three times in TBST, the membrane was incubated with Peroxidase conjugated goat anti-rabbit IgG (H+L) (ab97051) at 1/20,000 for 1hr at room temperature. The membrane was washed three times again. Then the signal was developed using the ECL technique. ab126732 was stored at a range of temperatures (+4°C, +22°C, +37°C) for 1 week before being tested in WB. The image shows the band intensity remains relatively constant across all storage temperatures, demonstrating that antibody activity is not affected.
All lanes:
Western blot - Anti-Amyloid Precursor Protein antibody [EPR5118-34] (ab126732) at 1/1000 dilution
All lanes:
HEK-293 whole cell lysate at 15 µg with NDFM/TBST
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
false
Exposure time: 80s
- WB
Lab
Western blot - Anti-Amyloid Precursor Protein antibody [EPR5118-34] (AB126732)
ab126732 was shown to react with APP in wild-type HAP1 cells in Western blot with loss of signal observed in a APP knockout cell line. Wild-type HAP1 and APP knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab126732 overnight at 4 °C at a 1/500 dilution. Blots were incubated with secondary antibodies at 0.2ug/mL before imaging.
These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-Amyloid Precursor Protein antibody [EPR5118-34] (ab126732) at 1/500 dilution
Lane 1:
Wild-type HAP1 lysate at 20 µg
Lane 2:
APP Knockout HAP1 lysate at 20 µg
Observed band size: 100 kDa
false
- WB
Lab
Western blot - Anti-Amyloid Precursor Protein antibody [EPR5118-34] (AB126732)
Lane 1 : Wild type HAP1 whole cell lysate (20 μg)
Lane 2 : APP knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HepG2 whole cell lysate (20 μg)
Lane 4 : HeLa whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab126732 observed at 110 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab126732 was shown to specifically react with APP when APP knockout samples were used. Wild-type and APP knockout samples were subjected to SDS-PAGE. ab126732 and ab9484 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1000 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Amyloid Precursor Protein antibody [EPR5118-34] (ab126732)
Predicted band size: 86 kDa
false
- WB
Unknown
Western blot - Anti-Amyloid Precursor Protein antibody [EPR5118-34] (AB126732)
All lanes:
Western blot - Anti-Amyloid Precursor Protein antibody [EPR5118-34] (ab126732) at 1/1000 dilution
Lane 1:
SH-SY5Y cell lysate at 10 µg
Lane 2:
293T cell lysate at 10 µg
Lane 3:
U-87 MG cell lysate at 10 µg
Lane 4:
Neuro 2a cell lysate at 10 µg
Lane 5:
C6 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 86 kDa
false
- WB
CiteAb
Western blot - Anti-Amyloid Precursor Protein antibody [EPR5118-34] (AB126732)
Amyloid Precursor Protein western blot using anti-Amyloid Precursor Protein antibody [EPR5118-34] ab126732. Publication image and figure legend from Mendsaikhan, A., Takeuchi, S., et al., 2019, Front Mol Neurosci, PubMed 30670947.
ab126732 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab126732 please see the product overview.
Expression of neuronal disease-associated proteins in FtMt clones. (A) Relative levels of amyloid precursor protein (APP) in different FtMt clones. Results shown represent mean ± SEM of triplicate experiments. Data analyzed by One way ANOVA with Tukey's post-hoc test of significance. Results indicate level of significance. *p < 0.05; **p < 0.01, ***p < 0.001, ****p < 0.0001. (B) Relative levels of Tau in different FtMt clones. Results shown represent mean ± SEM of triplicate experiments. Data analyzed by One way ANOVA with Tukey's post-hoc test of significance. Results indicate level of significance. *p < 0.05; **p < 0.01, ***p < 0.001, ****p < 0.0001. (C). Relative levels of α-synuclein (α-syn) in different FtMt clones. Results shown represent mean ± SEM of triplicate experiments. Data analyzed by One way ANOVA with Tukey's post-hoc test of significance. Results indicate level of significance. *p < 0.05. (D) Composite Western blot showing pattern of expression for APP, tau, and α-synuclein. Representative western blots of one experiment showing patterns of expression in untransfected and different FtMt clones. Experiment represents the sequential probing of single membrane for APP, tau, and α-synuclein followed by normalization for β-actin.
false
Related conjugates and formulations (8)
-
Anti-Amyloid Precursor Protein antibody [EPR5118-34] - BSA and Azide free
-
660 APC
APC Anti-Amyloid Precursor Protein antibody [EPR5118-34]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Amyloid Precursor Protein antibody [EPR5118-34]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-Amyloid Precursor Protein antibody [EPR5118-34]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Amyloid Precursor Protein antibody [EPR5118-34]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Amyloid Precursor Protein antibody [EPR5118-34]
-
HRP Anti-Amyloid Precursor Protein antibody [EPR5118-34]
-
578 PE
PE Anti-Amyloid Precursor Protein antibody [EPR5118-34]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Shipping conditions update: ambient shipping
This product will be delivered at ambient temperature instead of chilled – this is by design. Extensive stability testing confirmed that our products are suitable for shipment under ambient conditions and maintain expected quality.
Why the change?
It’s part of our commitment to more sustainable packaging solutions, with ambient deliveries using eco-friendly materials such as recyclable cardboard instead of polystyrene.
What you need to know
- Ambient shipments come clearly marked on the delivery note.
- No ice will be included in ambient shipments, but mixed orders (ambient and cold-chain items) will still arrive with ice packs to protect temperature-sensitive products.
- Warranty coverage remains fully valid, aligned with our validated shipping method.
- Please store the product as per the datasheet instructions upon receipt.
Find out more - https://www.abcam.com/en-us/support/shipping-storage-support/ambient-shipping
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The processing of APP plays a fundamental role in neuronal growth survival and repair. APP is cleaved into fragments that can regulate synaptic function and plasticity. It does not operate as a part of a complex but interacts with various cellular components. The protein participates in signaling pathways influencing cellular adhesion motility and neurite outgrowth. APP’s numerous interaction partners facilitate its involvement in different cellular processes highlighting its critical role in normal cell function.
Pathways
The APP is a central component in the amyloidogenic pathway where its cleavage by beta-secretase and gamma-secretase yields beta-amyloid. This pathway is one of two primary metabolic routes for APP—alternative enzymatic processing through the non-amyloidogenic pathway precludes beta-amyloid formation releasing peptides that do not aggregate. Enzymes like BACE1 (beta-secretase 1) and presenilin are important in the amyloidogenic pathway directly resulting in the production of the neurotoxic amyloid beta-peptide.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Alzheimer's & dementia : the journal of the Alzheimer's Association 21:e70093 PubMed40271543
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:111893 PubMed39995873
2025
Applications
Unspecified application
Species
Unspecified reactive species
F1000Research 12:956 PubMed39359612
2024
Applications
WB
Species
Human
Journal of Alzheimer's disease : JAD 101:823-834 PubMed39302370
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging 15:14172-14191 PubMed38095632
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Alzheimer's disease : JAD 95:1735-1755 PubMed37718819
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cells 12: PubMed36899882
2023
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 8:eabk2252 PubMed35675410
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35457188
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 11:2128 PubMed33483523
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com